Brinzolomide Active Pharmaceutical Ingredients

Send Inquiry

Request To Call Back

Brinzolomide Active Pharmaceutical Ingredients

Get a Price/Quote

MOQ : 25 Kilograms

Brinzolomide Active Pharmaceutical Ingredients Specification

Molecular Weight
383.51 g/mol

Structural Formula
Available on request

Loss on Drying
0.5%

Storage
Store in a cool, dry, and well-ventilated place, protected from light

Ph Level
Not applicable (insoluble in water)

Particle Size
Micronized; average particle size typically <10 microns

Taste
Bitter

Solubility
Slightly soluble in methanol and ethanol, practically insoluble in water

Shelf Life
36 months

Poisonous
No (when used as per prescription)

Smell
Odorless

Molecular Formula
C12H21N3O5S3

HS Code
29420090

Boiling point
Not applicable (decomposes before boiling)

Melting Point
>120C (decomposes)

Heavy Metal (%)
0.001% (10 ppm)

Color
White to off-white

Medicine Name
Brinzolomide

Chemical Name
Brinzolamide

CAS No
138890-62-7

Type
Active Pharmaceutical Ingredient (API)

Grade
Pharmaceutical Grade

Usage
Used in the formulation of eye drops for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma

Purity(%)
>=99%

Appearance
White to off-white crystalline powder

Physical Form
Solid

Packing Details
Packed in double polythene bags inside HDPE drum; customizable as per client requirements

Related Substances
Total impurities 1.0%

Identification Methods
By IR, HPLC, and Mass Spectrometry

Microbial Limit
Complies with pharmacopeial standards

Endotoxin Level
<0.25 EU/mg

Residual Solvents
Within ICH limits

Brinzolomide Active Pharmaceutical Ingredients Trade Information

Minimum Order Quantity
25 Kilograms

Payment Terms
Cash Against Delivery (CAD), Cash in Advance (CID), Cash on Delivery (COD)

Supply Ability
500 Kilograms Per Month

Delivery Time
5-7 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About Brinzolomide Active Pharmaceutical Ingredients

Experience instant checkout for Brinzolomide Active Pharmaceutical Ingredients-a must-have for pharmaceutical manufacturers seeking unrivaled purity and performance. Carefully selected for its pharmaceutical grade quality, this API is a polished solution meeting monumental industry benchmarks: total impurities 1.0%, microbial and endotoxin compliance, and exceptional purity of 99%. Formulated as a white to off-white crystalline powder, each batch is tested using advanced IR, HPLC, and mass spectrometry methods. Secure, customizable packaging ensures safe transport and handover. A pivotal choice for ocular hypertension therapies, offering both consistency and reliability.

Brinzolomide API Applications & Recommended Usage

Brinzolomide Active Pharmaceutical Ingredient is primarily applied in the pharmaceutical sector, particularly for the formulation of eye drops addressing elevated intraocular pressure in ocular hypertension or open-angle glaucoma. The application method involves precise blending into formulations during manufacturing, ensuring safety and efficacy. Used for both generic and branded medicine production, its micronized particle size ensures optimal absorption and therapeutic effectiveness, supporting monumental advancements in ophthalmic care.

Supply Ability, Certifications, and Markets for Brinzolomide API

Our monumental supply ability supports global handover tailored to any scale, from bulk to small volumes. Each shipment of Brinzolomide API is meticulously packaged in double polythene bags inside an HDPE drum for unrivaled protection, with customizable options available. Certified to meet rigorous pharmacopeial standards, this API commands trust in international markets. Main export destinations include Europe, North America, Southeast Asia, and Africa, offering prompt and reliable supply to discerning clients worldwide.

FAQ's of Brinzolomide Active Pharmaceutical Ingredients:

Q: How is Brinzolomide API identified and tested for quality?

A: Brinzolomide Active Pharmaceutical Ingredient undergoes identification and quality assessment using IR, HPLC, and Mass Spectrometry, ensuring compliance with pharmacopeial standards and verification of purity, impurities, and structural integrity.

Q: What applications is Brinzolomide API most commonly used for?

A: Brinzolomide API is widely used in the formulation of eye drops designed to treat elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma, making it vital in ophthalmic medicine.

Q: When should Brinzolomide-containing formulations be used?

A: Formulations containing Brinzolomide should be used as prescribed by healthcare professionals for managing ocular hypertension or open-angle glaucoma, following appropriate medical guidance.

Q: Where can Brinzolomide API be shipped from and what regions are covered?

A: We supply and export Brinzolomide API from India, serving major markets including Europe, North America, Southeast Asia, and Africa, ensuring global accessibility through secure packaging and trusted logistics.

Q: What benefit does the micronized particle size of this API provide?

A: The average micronized particle size of less than 10 microns enhances dispersion and absorption in ophthalmic formulations, leading to improved therapeutic outcomes and consistent dosing.

Q: How is Brinzolomide API packaged for supply?

A: Brinzolomide API is handover-ready, packed securely in double polythene bags inside an HDPE drum to protect against contamination and physical damage. Packaging can also be customized upon client request.

Tell us about your requirement